Levetiracetam Grindex oral solution 100 mg/ml. 300 ml. vial №1

$109.00

Manufacturer: Cyprus

Category:

Description

Monotherapy (first-choice drug) for: partial seizures with or without secondary generalization in adults and adolescents aged 16 and older who were first diagnosed with epilepsy. As an additional therapy for: partial seizures with or without secondary generalization in adults and children aged 1 month and older with epilepsy; myoclonic seizures in adults and adolescents aged 12 years and older, with juvenile myoclonic epilepsy; primary generalized tonic-clonic seizures in adults and adolescents aged 12 years and older, patients with idiopathic generalized epilepsy.